Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 521 entries
View as:

A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)

Phase: N/A Priority: Normal
NCT ID: NCT01391338 Org: User:
Start: 06/30/11 End: 02/28/13 Due: 02/28/14

A Study to Evaluate Safety and Tolerability of a Therapeutic Vaccine, ASP0113, in Subjects Undergoing Allogeneic Hematopoietic Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01903928 Org: User:
Start: 06/20/13 End: 01/19/15 Due: 01/19/16

Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males

Phase: N/A Priority: Normal
NCT ID: NCT01423435 Org: User:
Start: 08/31/11 End: 09/30/11 Due: 09/30/12

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00384137 Org: User:
Start: 10/31/06 End: 07/31/07 Due: 07/31/08

A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

Phase: N/A Priority: Normal
NCT ID: NCT00333112 Org: User:
Start: 05/31/06 End: 01/31/07 Due: 01/31/08

A Study to Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01747564 Org: User:
Start: 08/31/12 End: 10/31/12 Due: 10/31/13

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00282568 Org: User:
Start: 08/31/02 End: 10/31/08 Due: 10/31/09

A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01406158 Org: User:
Start: 05/31/11 End: 07/31/11 Due: 07/31/12

Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.

Phase: N/A Priority: Normal
NCT ID: NCT00296309 Org: User:
Start: 10/31/04 End: 08/31/06 Due: 08/31/07

Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01871974 Org: User:
Start: 05/31/09 End: 03/31/10 Due: 03/31/11

A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03219333 Org: User:
Start: 10/08/17 End: 07/28/23 Due: 07/28/24

A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150

Phase: N/A Priority: Normal
NCT ID: NCT01118559 Org: User:
Start: 11/30/09 End: 01/31/10 Due: 01/31/11

A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01484964 Org: User:
Start: 09/30/11 End: 10/31/11 Due: 10/31/12

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00938730 Org: User:
Start: 06/30/09 End: 09/30/10 Due: 09/30/11

Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection

Phase: N/A Priority: Normal
NCT ID: NCT00133172 Org: User:
Start: 07/31/05 End: 03/31/07 Due: 03/31/08

To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females

Phase: N/A Priority: Normal
NCT ID: NCT01478503 Org: User:
Start: 05/31/05 End: 10/31/05 Due: 10/31/06

Drug Interaction Study of Isavuconazole and Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT01406171 Org: User:
Start: 05/31/11 End: 06/30/11 Due: 06/30/12

Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01430065 Org: User:
Start: 06/30/09 End: 06/30/09 Due: 06/30/10

A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

Phase: N/A Priority: Normal
NCT ID: NCT00673556 Org: User:
Start: 10/31/03 End: 05/31/05 Due: 05/31/06

A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00454233 Org: User:
Start: 02/28/07 End: 06/30/08 Due: 06/30/09

Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Mycophenolate Mofetil in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01364987 Org: User:
Start: 05/31/09 End: 06/30/09 Due: 06/30/10

A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00850746 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10

A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)

Phase: N/A Priority: Normal
NCT ID: NCT01533428 Org: User:
Start: 02/29/12 End: 02/28/14 Due: 02/28/15

A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00106392 Org: User:
Start: 02/28/05 End: 11/30/08 Due: 11/30/09

A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015K

Phase: N/A Priority: Normal
NCT ID: NCT01486017 Org: User:
Start: 09/30/11 End: 09/30/11 Due: 09/30/12